These cells can stimulate VEGF-dependent neoangiogenesis and actively participate in alternative tumor vascularization, known as vasculogenic mimicry (VM) (Knopik-Skrocka et al., 2017[64]). The gene discussed is VEGFA; the disease is neoplasm.